Study on clinical application of aromatherapy for patients with fibromyalgia
- Conditions
- fibromyalgia
- Registration Number
- JPRN-UMIN000043490
- Lead Sponsor
- International University of Health and Welfare Shioya Hospital Anesthesiology
- Brief Summary
There was no significant difference in blood pressure before and after the treatment in both the control group and the geranium essential oil group. Heart rate after the treatment showed a decreasing trend in the control group and a significant decrease in the geranium essential oil group. The STAI score for assessing pain stress in fibromyalgia patients was not significantly different in the control group and the geranium essential oil group. Translated with www.DeepL.com/Translator (free version)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Not provided
1. Women who are pregnant or may be pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method At the consultation, the pain clinic doctor measures the numeric rating scale, pain disability assessment scale, EuroQol, and Self-Rating Depression Scale on an outpatient basis.
- Secondary Outcome Measures
Name Time Method Observation and inspection are performed for the following items. Also, we will ask for a response to the questionnaire and use the data for this study. These are activities that go beyond normal practice and are performed for research purposes. 1) Basic patient information: age, gender, medical history, height, weight, etc. 2) Blood test 3) Evaluation items of State trait Anxiety Inventery (STAI), numeric rating scale, Pain disability assessment scale, EuroQol, and Self-Rating Depression Scale measured by the attending physician before and after aromatherapy was performed. 4) Biomarkers in saliva (chromogranin A, cortisol, alpha-amylase) 5) Blood pressure and heart rate 6) Oral medication